FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to method of human blood coagulation VIII factor production and related product. Method includes blood serum as cryoprecipitate, heparine added, PEG-4000, centrifugation, supernatant is added with tributyl phosphate and Twin-80, repeated centrifugation, sediment washed with sodium chloride, then it is dissolved in tris-HCl buffer with additives, let through column filled with gel and attached antibodies to Willebrand's factor, factor VIII elution, dialysis. Produced concentrate does not contain Willebrand's factor and has activity not less than 300 ME/mg of protein with purity not less 98% and contains albumin of concentration of 0.1%. Product is lyophilized with further processing.
EFFECT: product does not display any toxicity and cause allergic reaction.
6 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING FACTOR VIII PREPARATION | 2004 |
|
RU2253475C1 |
| METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
| METHOD OF MAKING PREPARATION OF HUMAN BLOOD COAGULATON FACTOR VIII | 2006 |
|
RU2324495C1 |
| METHOD FOR SEPARATION OF BLOOD PROTEINS | 0 |
|
SU1837880A3 |
| METHOD OF OBTAINING FIBRINOGEN CONCENTRATE | 2013 |
|
RU2556804C2 |
| METHOD FOR PREPARING HUMAN C-1 ESTERASE INHIBITOR AMD PRODUCT FOR USING IN MEDICINE | 2004 |
|
RU2256464C1 |
| METHOD FOR PRODUCING PURIFIED ACTIVATED BLOOD COAGULATION X-FACTOR | 2002 |
|
RU2221578C1 |
| METHOD FOR ISOLATION OF HIGHLY PURIFIED COMPLEX OF VIII FACTOR FROM WILLEBRANDE FACTOR | 1993 |
|
RU2096414C1 |
| METHOD OF PREPARING OF CONCENTRATE OF FACTOR VIII AND VON VILLEBRAND FACTOR | 1990 |
|
RU2025129C1 |
| METHOD FOR CRYOPRESERVATION OF INTERMEDIATE PRODUCT OF BLOOD COAGULATION FACTOR VIII | 2019 |
|
RU2814332C1 |
